Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karen Chandross is active.

Publication


Featured researches published by Karen Chandross.


Annals of Neurology | 2006

Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation

Fraser J. Sim; Jennifer K. Lang; Ben Waldau; Neeta S. Roy; Theodore E. Schwartz; Webster H. Pilcher; Karen Chandross; Sridaran Natesan; Jean Merrill; Steven A. Goldmanm

Glial progenitor cells are abundant in adult human white matter. This study was designed to identify signaling pathways regulating their self‐renewal and fate.


Journal of Neurochemistry | 2004

17beta‐estradiol protects oligodendrocytes from cytotoxicity induced cell death

Toshihiro Takao; Nicole Flint; Lan Lee; Xiaoyou Ying; Jean Merrill; Karen Chandross

During pregnancy, changes in circulating levels of hormones, including estrogens, correlates with a significant decrease in the relapse incidence in women with Multiple Sclerosis (MS). In the present study, we demonstrate that both primary and cell line cultures of rat oligodendrocytes express the estrogen receptor (ER)‐α and ERβ estrogen receptors in the cytosol and nucleus, and that nuclear compartmentalization becomes more pronounced as the cells mature. Moreover, 17β‐estradiol significantly decreases the cytotoxic effects of the peroxynitrite generator 3‐(4‐morpholinyl)‐sydnonimine (SIN‐1) in both immature and mature oligodendrocytes in a dose dependent manner. This protective mechanism requires pretreatment with 17β‐estradiol and is blocked by ICI 182,780, a selective ERα/ERβ antagonist. These results strongly suggest that 17β‐estradiol protects oligodendrocytes against SIN‐1 mediated cytotoxicity through the activation of the estrogen receptors and provides new insights into the roles of the estrogen signaling pathways in myelin forming cells that are lost in demyelinating disorders.


Archive | 2006

Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals

Patrick Bernardelli; Stefanie Keil; Matthias Urmann; Hans Matter; Wolfgang Wendler; Maike Glien; Karen Chandross; Lan Lee; Corinne Terrier; Hervé Minoux


Archive | 2006

Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals

Stefanie Keil; Matthias Urmann; Patrick Bernardelli; Maike Glien; Wolfgang Wendler; Karen Chandross; Lan Lee


Archive | 2005

Oxadiazolones, processes for their preparation and their use as pharmaceuticals

Stefanie Keil; Wolfgang Wendler; Maike Glien; Jochen Goerlitzer; Karen Chandross; Daniel G. Mcgarry; Jean Merril; Patrick Bernardelli; Baptiste Ronan; Corinne Terrier


Archive | 2005

1,3,4-oxadiazol-2-ones as ppar delta modulators

Daniel G. Mcgarry; Karen Chandross; Jean Merrill; Jochen Goerlitzer; Stefanie Keil; Wolfgang Wendler; Patrick Bernardelli


Archive | 2006

1,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereof

Daniel G. Mcgarry; Karen Chandross; Jean Merrill; Jochen Goerlitzer; Stefanie Keil; Wolfgang Wendler; Patrick Bernardelli


Archive | 2005

Use of ppr delta agonists for treating demyelinating diseases

Karen Chandross; Jean Merrill; Anne Minnich; Lan Lee; Olga Khorkova; Yun Liu


Archive | 2005

Oxadiazolone derivatives as ppar delta agonists

Stefanie Keil; Wolfgang Wendler; Maike Glien; Jochen Goerlitzer; Karen Chandross; Daniel G. Mcgarry; Jean Merrill; Patrick Bernardelli; Baptiste Ronan; Corinne Terrier


Archive | 2008

Phenyl-1,2,4-Oxadiazolone Derivatives, Processes For Their Preparation and Methods For Their Use as Pharmaceuticals

Stefanie Keil; Matthias Urmann; Patrick Bernardelli; Maike Glien; Wolfgang Wendler; Karen Chandross; Lan Lee

Collaboration


Dive into the Karen Chandross's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge